The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results